Insight Molecular Diagnostics IMDX
NASDAQ IMDX
$3.59 +0.21 (+6.21%)
At close: Sep 30, 2026 · 4:00 PM EDT

Insight Molecular Diagnostics (IMDX) Total Non-Current Liabilities (2019 - 2026)

Updated

Insight Molecular Diagnostics (IMDX) reported Total Non-Current Liabilities of $11.2 million for Q2 2026, up 32.0% from $8.49 million a year earlier but down 15.9% from the prior quarter.

Analysis

Insight Molecular Diagnostics (IMDX) Total Non-Current Liabilities (2019 - 2026) Analysis & Trends

At the end of FY2025, Insight Molecular Diagnostics posted Total Non-Current Liabilities of $13.77 million, up 42.7% from FY2024.

  • Total Non-Current Liabilities has a five-year compound annual growth rate of -1.5% (FY2020 to FY2025).
  • By year, Total Non-Current Liabilities came in at $9.64 million in FY2024 (-33.6%), $14.52 million in FY2023 (-27.9%), $20.14 million in FY2022 (+14.0%) and $17.67 million in FY2021 (+19.2%).
  • Five-year quarterly Total Non-Current Liabilities spans a low of $8.49 million in Q2 2025 and a high of $22.14 million in Q2 2022.
  • Year over year, Total Non-Current Liabilities has now increased in each of the last three quarters, with an average decline of 4.8% over the last eight quarters.
  • The high point for year-over-year Total Non-Current Liabilities in five years was Q3 2021 (growth of 44.2%); the low point was Q4 2024 (a decline of 33.6%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $13.31 million (Q1 2026), $13.77 million (Q4 2025) and $9.19 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Thermo Fisher Scientific 251.30 Bn 230.45 Bn 4.88 Bn 55.95 Bn
2 Abbott Laboratories 174.70 Bn 145.78 Bn 7.27 Bn -
3 Danaher 158.94 Bn 142.76 Bn 3.61 Bn 33.25 Bn
4 Intuitive Surgical 145.87 Bn 125.42 Bn 1.96 Bn -
5 Medtronic 111.49 Bn 77.36 Bn 6.34 Bn 40.46 Bn
6 Stryker 106.96 Bn 93.08 Bn 4.50 Bn 21.28 Bn
7 Boston Scientific 63.62 Bn 58.63 Bn 3.85 Bn 17.56 Bn
8 Edwards Lifesciences 50.80 Bn 34.92 Bn 1.35 Bn 2.57 Bn
9 Becton Dickinson 49.59 Bn 46.74 Bn 2.32 Bn 23.92 Bn
10 Insight Molecular Diagnostics 110.27 Mn 33.98 Mn 157,000.00 11.20 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 11.20 Mn
Mar 31, 2026 13.31 Mn
Dec 31, 2025 13.77 Mn
Sep 30, 2025 9.19 Mn
Jun 30, 2025 8.49 Mn
Mar 31, 2025 11.76 Mn
Dec 31, 2024 9.64 Mn
Sep 30, 2024 11.80 Mn
Jun 30, 2024 9.84 Mn
Mar 31, 2024 16.17 Mn
Dec 31, 2023 14.52 Mn
Sep 30, 2023 16.73 Mn
Jun 30, 2023 14.79 Mn
Mar 31, 2023 17.51 Mn
Dec 31, 2022 20.14 Mn
Sep 30, 2022 20.96 Mn
Jun 30, 2022 22.14 Mn
Mar 31, 2022 17.28 Mn
Dec 31, 2021 17.67 Mn
Sep 30, 2021 17.32 Mn
API Access

Insight Molecular Diagnostics Total Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=IMDX&period=max&api_key=YOUR_API_KEY